CardioMAX by Renue By Science — Ingredients, Evidence & Safety

Product Label

📄 Open Full PDF View on NIH DSLD →

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

⚠️ Niacin: 125mg is 3.6× the Tolerable Upper Intake Level (35mg)

Label Data

2 Vegetarian Capsule(s) Serving Size

60 Servings

Non-Nutrient/Non-Botanical Product Type

100% Evidence Coverage

Supplement Facts — Evidence Check

Red Yeast Rice

400 mg

📊 Market median: 1000.0mg (223 products) 📚 11 studies (Tier A: 0, B: 5)

This product: 400mg

Niacin

125 mg

⚠️ Exceeds Tolerable Upper Intake Level by 3.6× (UL: 35 mg) 📚 193 studies (Tier A: 5, B: 63)

RDA 14mg This product: 125mg UL 35mg

Coenzyme Q-10

100 mg

📊 Market median: 100.0mg (283 products) 📚 142 studies (Tier A: 1, B: 64)

This product: 100mg UL 1200mg

Berberine

100 mg

📊 Market median: 500.0mg (234 products) 📚 95 studies (Tier A: 0, B: 35)

This product: 100mg

Other Ingredients

Cellulose Sunflower Lecithin Rice Flour Microcrystalline Cellulose

Label Claims — Verification

❓ Nutrient

❓ All Other

❓ Structure/Function

All Other (99% of products) Structure/Function (74% of products) Nutrient (7% of products)

Target Groups

Vegan Vegetarian Adult (18 - 50 Years) Dairy Free

Product Information

📋 Directions for Use

Suggested use Take two (2) capsules daily with or without food.

⚠️ Warnings & Precautions

Pregnant or nursing mothers. children under the age of 18, and individuals with a known medical condition should consult a physician before using.

May be taken with or without food. Do not use if safety seal is broken or missing.

🧪 Formulation Notes

CardioMAX is formulated with patented liposome technology to increase bioavailability and is designed to offer advanced cardiovascular and cholesterol support.

This product is manufactured in the United States at a FDA registered facility under strict GMP standards.

Heart health & cholesterol support

Powdered Liposomes

No artificial colors, flavors or preservatives. Non-GMO.

Suitable for vegans.

Additional Information

Store in a cool, dry place.

GMP Good manufacturing practice certified

Product Details

UPC / SKU 6 56165 99671 1

DSLD Entry Date 2024-09-25

Product Type Non-Nutrient/Non-Botanical

Form Capsule

Brand Renue By Science

DSLD ID 318988

Data Updated 2026-04-11

Research Evidence

13 Research Sources

53 Avg Quality Score

5 Rct

5 Meta Analysis

2 Clinical Trial

1 Regulatory Source

B Impact of red yeast rice supplementation on lipid profile: a systematic review and meta-analysis of randomized-controlled trials

Meta Analysis Expert review of clinical pharmacology 2023

PubMed DOI

B Low Dose Monacolin K Combined with Coenzyme Q10, Grape Seed, and Olive Leaf Extracts Lowers LDL Cholesterol in Patients with Mild Dyslipidemia: A Multicenter, Randomized Controlled Trial

Rct Nutrients 2023

PubMed DOI

B Original Research: The Effects of Red Yeast Rice Supplementation on Cholesterol Levels in Adults

Meta Analysis The American journal of nursing 2017

PubMed DOI

B Randomized, Double-Blind, Placebo-Controlled Trial to Test the Effects of a Nutraceutical Combination Monacolin K-Free on the Lipid and Inflammatory Profile of Subjects with Hypercholesterolemia

Rct Nutrients 2022

PubMed DOI

B Low dose red yeast rice with monacolin K lowers LDL cholesterol and blood pressure in Japanese with mild dyslipidemia: A multicenter, randomized trial

Rct Asia Pacific journal of clinical nutrition 2021

PubMed DOI

C Impact of Monacolin K-Containing Supplements on Lipid Profile: A Meta-Analysis of Randomised Controlled Trials

Meta Analysis Endocrinology, diabetes & metabolism 2026

PubMed DOI

C Traditional Chinese lipid-lowering agent red yeast rice results in significant LDL reduction but safety is uncertain - a systematic review and meta-analysis

Meta Analysis Atherosclerosis 2015

PubMed DOI

C Effects of a nutraceutical combination containing berberine (BRB), policosanol, and red yeast rice (RYR), on lipid profile in hypercholesterolemic patients: A meta-analysis of randomised controlled trials

Meta Analysis Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis 2016

PubMed DOI

C Can red yeast rice and olive extract improve lipid profile and cardiovascular risk in metabolic syndrome?: A double blind, placebo controlled randomized trial

Rct BMC complementary and alternative medicine 2015

PubMed DOI

C No additional cholesterol-lowering effect observed in the combined treatment of red yeast rice and Lactobacillus casei in hyperlipidemic patients: A double-blind randomized controlled clinical trial

Rct Chinese journal of integrative medicine 2017

PubMed DOI

View all evidence for Red Yeast Rice →